Bioperfectus working together with ICGEB in the field of infectious disease product research

Company news

We Bioperfectus are honored to work together with ICGEB (International Center for Genetic Engineering and Biotechnology) in the field of infectious disease products’ clinical research. As the world’s leading intergovernmental organization for research, training and technology transfer in the field of Life Sciences and Biotechnology, ICGEB combines scientific research with capacity enhancement, thereby promoting sustainable global development. In the common vision to provide an accurate, rapid and accessible diagnostic solution for all the human race in the world, Bioperfectus is one of the leading in vitro diagnostic manufacturers specialized in molecular diagnostic solution & rapid test in the global IVD market.


Bioperfectus, working for a healthier life endlessly.




Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.


Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.


Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).